Fengzhou Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- RNA modifications and cancer 4
- RNA Research and Splicing 3
- Glycosylation and Glycoproteins Research 2
-
- Lung Cancer Treatments and Mutations 5
- Ferroptosis and cancer prognosis 2
- Co-authors
- Chundong Gu (17 shared papers)Lei Fang (6 shared papers)Shilei Zhao (13 shared papers)Wendan Yu (6 shared papers)Wei Guo (5 shared papers)Wuguo Deng (4 shared papers)Yixiang Zhang (3 shared papers)Qingkai Yang (1 shared paper)
- Journals
- BioMed Research International (4 papers)Cell Death and Disease (3 papers)Human Cell (2 papers)Biochemical and Biophysical Research Communications (1 paper)Advanced Science (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Fengzhou Li
27 papers receiving 572 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 115
- Oncology 140
- Immunology 82
- Molecular Biology 252
- Pulmonary and Respiratory Medicine 98
Countries citing papers authored by Fengzhou Li
This map shows the geographic impact of Fengzhou Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengzhou Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengzhou Li more than expected).
Fields of papers citing papers by Fengzhou Li
This network shows the impact of papers produced by Fengzhou Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengzhou Li. The network helps show where Fengzhou Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengzhou Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 123 | |
| 2 | 2021 | 58 | |
| 3 | 2020 | 52 | |
| 4 | α1,6-Fucosyltransferase (FUT8) regulates the cancer-promoting capacity of cancer-associated fibroblasts (CAFs) by modifying EGFR core fucosylation (CF) in non-small cell lung cancer (NSCLC). | 2020 | 35 |
| 5 | 2020 | 34 | |
| 6 | 2016 | 32 | |
| 7 | 2017 | 30 | |
| 8 | 2019 | 28 | |
| 9 | 2019 | 23 | |
| 10 | 2021 | 20 | |
| 11 | 2021 | 19 | |
| 12 | 2023 | 18 | |
| 13 | 2019 | 16 | |
| 14 | 2019 | 14 | |
| 15 | 2021 | 11 | |
| 16 | 2019 | 10 | |
| 17 | 2020 | 9 | |
| 18 | 2024 | 7 | |
| 19 | 2023 | 7 | |
| 20 | 2018 | 7 |
About Fengzhou Li
Fengzhou Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Endocrine and Autonomic Systems, having authored 28 papers that have together received 574 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers), RNA Research and Splicing (3 papers), Ferroptosis and cancer prognosis (2 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer Cells and Metastasis (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Cancer Research (115 citations), Oncology (140 citations), Immunology (82 citations), Molecular Biology (252 citations) and Pulmonary and Respiratory Medicine (98 citations). Fengzhou Li has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Chundong Gu, Lei Fang, Shilei Zhao, Wendan Yu, Wei Guo, Wuguo Deng, Yixiang Zhang, Qingkai Yang, Songyu Li and Changsheng Lv. Their work appears in journals such as BioMed Research International, Cell Death and Disease, Human Cell, Biochemical and Biophysical Research Communications and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.